ArticleOncotarget2018

Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer.

Hiroaki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.